Literature DB >> 30641485

Forgotten but Not Gone: Learning From the Hepatitis A Outbreak and Public Health Response in San Diego.

Darcy A Wooten1.   

Abstract

The recent hepatitis A virus (HAV) outbreak in San Diego was driven by homelessness, associated sanitation conditions, and illicit drug use. As with an outbreak in Michigan, fueled by similar factors, morbidity and mortality were higher than what has been observed with post-vaccine era foodborne HAV outbreaks. Control of the outbreak in San Diego was accomplished with vaccine, sanitation, and education initiatives that targeted those at highest risk. Mass vaccination events and mobile foot teams and vans brought education and vaccine to high-risk individuals in affected areas. The homelessness crisis in San Diego and in many locales throughout the United States poses risk of increasing numbers of outbreaks of HAV and other infectious illnesses. This article summarizes an IAS-USA continuing education webinar given by Darcy A. Wooten, MD, on July 19, 2018.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30641485      PMCID: PMC6372360     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  8 in total

Review 1.  Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention.

Authors:  Ameer Abutaleb; Shyam Kottilil
Journal:  Gastroenterol Clin North Am       Date:  2020-03-29       Impact factor: 3.806

2.  Hepatitis A Outbreaks Associated With the Opioid Epidemic in Kentucky Counties, 2017-2018.

Authors:  Natalie DuPre; Lyndsey Blair; Sarah Moyer; E Francis Cook; Bert Little; Jeffrey Howard
Journal:  Am J Public Health       Date:  2020-07-16       Impact factor: 11.561

3.  Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States.

Authors:  Emmanuelle A Dankwa; Christl A Donnelly; Andrew F Brouwer; Rui Zhao; Martha P Montgomery; Mark K Weng; Natasha K Martin
Journal:  Vaccine       Date:  2021-10-20       Impact factor: 4.169

4.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

5.  Emergency Department-based Hepatitis A Vaccination Program in Response to an Outbreak.

Authors:  Caroline Kaigh; Andrea Blome; Kraftin E Schreyer; Megan Healy
Journal:  West J Emerg Med       Date:  2020-07-10

6.  Identifying Missed Opportunities for Routine Vaccination among People Who Use Drugs.

Authors:  Paula M Frew; Jay T Schamel; Laura A Randall; Adrian R King; Ian W Holloway; Katherine Burris; Anne C Spaulding
Journal:  Int J Environ Res Public Health       Date:  2021-02-04       Impact factor: 3.390

7.  HIV and the liver.

Authors:  Kenneth E Sherman; Marion G Peters; David L Thomas
Journal:  Top Antivir Med       Date:  2019-09

8.  Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1-/- Mice.

Authors:  Ichiro Misumi; Zhucui Li; Lu Sun; Anshuman Das; Tomoyuki Shiota; John Cullen; Qibin Zhang; Jason K Whitmire; Stanley M Lemon
Journal:  J Virol       Date:  2021-05-10       Impact factor: 6.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.